依特钠(AEZS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AEZS 依特钠

盘前交易 07-22 06:10:23 EDT

5.85

-0.12

-2.06%

最高6.00	最低5.66	成交量1,508
今开6.00	昨收5.97	日振幅5.73%
总市值1,791万	流通市值1,662万	总股本306.16万
成交额8,786	换手率0.05%	流通股本284.02万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AEZS","market":"US","secType":"STK","nameCN":"依特钠","latestPrice":5.85,"timestamp":1721419200000,"preClose":5.9729,"halted":0,"volume":1508,"delay":0,"floatShares":2840200,"shares":3061560,"eps":-14.863927,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.1229,"latestTime":"07-22 06:10:23 EDT","open":5.997,"high":5.997,"low":5.655,"amount":8785.847772,"amplitude":0.057259,"askPrice":9.13,"askSize":200,"bidPrice":4.46,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-14.863927,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":957931200000,"adjPreClose":5.71,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":5.85,"preClose":5.85,"latestTime":"16:43 EDT","volume":8,"amount":45.68,"timestamp":1721421782375},"volumeRatio":0.5563344237488038,"impliedVol":7.785,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/AEZS/tweets","defaultTab":"tweets","newsList":[{"id":"2451804628","title":"依特钠盘中异动 快速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451804628","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451804628?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:32","pubTimestamp":1721050350,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时32分，依特钠股票出现异动，股价快速下跌5.04%。截至发稿，该股报6.00美元/股，成交量296股，换手率0.01%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为0.18%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152132319f4f23a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152132319f4f23a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2450533290","title":"依特钠盘中异动 股价大跌7.75%报6.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450533290","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450533290?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:35","pubTimestamp":1720791343,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时35分，依特钠股票出现波动，股价大幅下跌7.75%。截至发稿，该股报6.31美元/股，成交量475股，换手率0.02%，振幅0.00%。依特钠股票所在的生物技术行业中，整体涨幅为0.58%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213544af921ccf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213544af921ccf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2450690663","title":"依特钠盘中异动 早盘快速跳水5.64%报6.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450690663","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450690663?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:40","pubTimestamp":1720708813,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时40分，依特钠股票出现异动，股价快速下跌5.64%。截至发稿，该股报6.52美元/股，成交量5769股，换手率0.19%，振幅7.53%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.74%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711224014941f64e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711224014941f64e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2450813803","title":"依特钠盘中异动 大幅拉升5.65%报7.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450813803","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450813803?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:34","pubTimestamp":1720618466,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时34分，依特钠股票出现波动，股价急速拉升5.65%。截至发稿，该股报7.27美元/股，成交量3178股，换手率0.10%，振幅2.47%。依特钠股票所在的生物技术行业中，整体涨幅为0.15%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213426aef8fc38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213426aef8fc38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2450026865","title":"依特钠盘中异动 早盘急速上涨13.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450026865","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450026865?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:09","pubTimestamp":1720534198,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时09分，依特钠股票出现异动，股价大幅上涨13.24%。截至发稿，该股报5.95美元/股，成交量2897股，换手率0.09%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为1.05%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709220958941f571d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709220958941f571d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2449094017","title":"依特钠盘中异动 股价大涨8.42%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449094017","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449094017?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:28","pubTimestamp":1720448898,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时28分，依特钠股票出现异动，股价大幅上涨8.42%。截至发稿，该股报5.15美元/股，成交量960股，换手率0.03%，振幅2.75%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.83%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222819941f4f28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222819941f4f28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2448164166","title":"依特钠盘中异动 早盘股价大跌5.96%报4.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448164166","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448164166?lang=zh_cn&edition=full","pubTime":"2024-07-02 23:25","pubTimestamp":1719933957,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日23时25分，依特钠股票出现波动，股价急速下跌5.96%。截至发稿，该股报4.42美元/股，成交量461股，换手率0.02%，振幅3.43%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为0.86%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702232557aef79bc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702232557aef79bc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2448916967","title":"依特钠盘中异动 早盘股价大涨9.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448916967","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448916967?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:17","pubTimestamp":1719843464,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时17分，依特钠股票出现异动，股价急速上涨9.16%。截至发稿，该股报4.83美元/股，成交量332股，换手率0.01%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.78%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701221744aef76ef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701221744aef76ef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2445009839","title":"依特钠盘中异动 早盘急速拉升5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445009839","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445009839?lang=zh_cn&edition=full","pubTime":"2024-06-24 23:23","pubTimestamp":1719242625,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日23时23分，依特钠股票出现异动，股价快速拉升5.51%。截至发稿，该股报4.84美元/股，成交量4882股，换手率0.40%，振幅4.69%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为1.86%。依特钠公司简介：AEterna Zentaris Inc 是一家致力于商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406242323469681647f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406242323469681647f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2445750084","title":"依特钠盘中异动 早盘股价大涨5.51%报4.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445750084","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445750084?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:31","pubTimestamp":1718976664,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时31分，依特钠股票出现波动，股价大幅拉升5.51%。截至发稿，该股报4.87美元/股，成交量717股，换手率0.06%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.27%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621213104941f01e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621213104941f01e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2444214905","title":"依特钠盘中异动 快速下跌7.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444214905","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444214905?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:31","pubTimestamp":1718890294,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时31分，依特钠股票出现异动，股价大幅跳水7.59%。截至发稿，该股报5.60美元/股，成交量73股，换手率0.01%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.13%。依特钠公司简介：AEterna Zentaris Inc 是一家致力于商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213134941efd37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213134941efd37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2444944011","title":"依特钠盘中异动 股价大跌6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444944011","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444944011?lang=zh_cn&edition=full","pubTime":"2024-06-18 00:25","pubTimestamp":1718641531,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日00时25分，依特钠股票出现波动，股价急速下跌6.90%。截至发稿，该股报6.00美元/股，成交量3264股，换手率0.27%，振幅2.02%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为0.56%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061800253196814ac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061800253196814ac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2442127853","title":"依特钠盘中异动 大幅跳水5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442127853","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442127853?lang=zh_cn&edition=full","pubTime":"2024-06-12 01:29","pubTimestamp":1718126982,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日01时29分，依特钠股票出现异动，股价大幅跳水5.62%。截至发稿，该股报6.89美元/股，成交量3751股，换手率0.31%，振幅3.70%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为0.34%。依特钠公司简介：AEterna Zentaris Inc 是一家致力于商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612012943aef45f50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612012943aef45f50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2441704744","title":"依特钠盘中异动 大幅下跌5.85%报7.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441704744","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441704744?lang=zh_cn&edition=full","pubTime":"2024-06-07 00:15","pubTimestamp":1717690522,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日00时15分，依特钠股票出现波动，股价急速下跌5.85%。截至发稿，该股报7.33美元/股，成交量2019股，换手率0.07%，振幅1.45%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.40%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060700152296812a55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060700152296812a55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2441367279","title":"依特钠盘中异动 股价大跌7.84%报7.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441367279","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441367279?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:34","pubTimestamp":1717594442,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日21时34分，依特钠股票出现波动，股价急速跳水7.84%。截至发稿，该股报7.52美元/股，成交量399股，换手率0.01%，振幅5.27%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.16%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060521340295914fe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060521340295914fe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2440423923","title":"依特钠盘中异动 早盘股价大跌5.01%报8.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440423923","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440423923?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:14","pubTimestamp":1717510473,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时14分，依特钠股票出现波动，股价大幅下跌5.01%。截至发稿，该股报8.16美元/股，成交量1169股，换手率0.10%，振幅1.28%。最近的财报数据显示，该股实现营业收入4000.00美元，净利润-5.75百万美元，每股收益-18.95美元，毛利-56000.00美元，市盈率-0.55倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604221433af8bef8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604221433af8bef8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2432052980","title":"依特钠盘中异动 股价大跌5.26%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432052980","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432052980?lang=zh_cn&edition=full","pubTime":"2024-05-03 01:07","pubTimestamp":1714669643,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日01时07分，依特钠股票出现波动，股价急速跳水5.26%。截至发稿，该股报1.98美元/股，成交量1.055万股，换手率0.22%，振幅7.66%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为1.06%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030107247925b522&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030107247925b522&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2432508202","title":"依特钠盘中异动 快速上涨5.13%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432508202","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432508202?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:53","pubTimestamp":1714571603,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时53分，依特钠股票出现异动，股价快速上涨5.13%。截至发稿，该股报2.05美元/股，成交量4.277万股，换手率0.88%，振幅5.13%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.36%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012153247a57dc1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012153247a57dc1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2432588614","title":"依特钠盘中异动 股价大涨6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432588614","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432588614?lang=zh_cn&edition=full","pubTime":"2024-05-01 02:37","pubTimestamp":1714502242,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日02时37分，依特钠股票出现波动，股价快速上涨6.02%。截至发稿，该股报2.07美元/股，成交量8752股，换手率0.18%，振幅2.05%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.24%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010237227a57ca39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010237227a57ca39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2422113867","title":"依特钠2023财年实现净利润-16.55百万美元，同比增加27.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422113867","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422113867?lang=zh_cn&edition=full","pubTime":"2024-03-28 22:11","pubTimestamp":1711635114,"startTime":"0","endTime":"0","summary":"12月31日，依特钠公布财报，公告显示公司2023财年净利润为-16.55百万美元，同比增加27.19%；其中营业收入为4.50百万美元，同比减少20.21%，每股基本收益为-3.41美元。从资产负债表来看，依特钠总负债18.82百万美元，其中短期债务160000.00美元，资产负债比为1.97，流动比率为8.02。机构评级：截至2023年12月31日，当前有1家机构对依特钠目标价做出预测，其中目标均价为15.00美元，其中最低目标价为15.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032822115787c10379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032822115787c10379&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zentaris.com","stockEarnings":[{"period":"1week","weight":-0.0741},{"period":"1month","weight":-0.0346},{"period":"3month","weight":-0.25},{"period":"6month","weight":-0.2688},{"period":"1year","weight":-0.5415},{"period":"ytd","weight":-0.2137}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aeterna Zentaris, Inc.于1990年9月12日 ，在Canada Business Corporations Act名下成立，并继续受其管理。Aeterna Zentaris是一家晚期药物的开发公司，专业从事肿瘤学和内分泌治疗。公司产品线包括从开发到销售所有阶段的化合物。公司的主要业务战略是与战略合作伙伴共同进步，其产品开发线上的重点候选产品主要用于肿瘤学和内分泌学领域。此外，该公司还继续推进其他临床和临床前程序，其中一些通过了不同政府机构的授权。公司的愿景是成为一个综合的专业生物制药公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.049213},{"month":2,"riseRate":0.458333,"avgChangeRate":0.00928},{"month":3,"riseRate":0.458333,"avgChangeRate":-0.011313},{"month":4,"riseRate":0.541667,"avgChangeRate":0.065619},{"month":5,"riseRate":0.5,"avgChangeRate":0.042204},{"month":6,"riseRate":0.24,"avgChangeRate":-0.097582},{"month":7,"riseRate":0.32,"avgChangeRate":-0.026454},{"month":8,"riseRate":0.5,"avgChangeRate":-0.039826},{"month":9,"riseRate":0.291667,"avgChangeRate":-0.061538},{"month":10,"riseRate":0.291667,"avgChangeRate":-0.046147},{"month":11,"riseRate":0.5,"avgChangeRate":0.058342},{"month":12,"riseRate":0.5,"avgChangeRate":-0.01243}],"exchange":"NASDAQ","name":"依特钠","nameEN":"AEterna Zentaris"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"依特钠(AEZS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供依特钠(AEZS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"依特钠,AEZS,依特钠股票,依特钠股票老虎,依特钠股票老虎国际,依特钠行情,依特钠股票行情,依特钠股价,依特钠股市,依特钠股票价格,依特钠股票交易,依特钠股票购买,依特钠股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"依特钠(AEZS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供依特钠(AEZS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}